torque technique for EUS-guided FNB in solid pancreatic masses
Not Applicable
Recruiting
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0002338
- Lead Sponsor
- Hallym University Medical Center-Dongtan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 118
Inclusion Criteria
Patients were eligible for the study based on the following criteria: suspected solid pancreatic masses based on clinical work up and image modality that required cytopathological confirmation.
Exclusion Criteria
Exclusion criteria included:
(a) cystic pancreatic lesions without the evidence of solid component suspected with malignant transformation;
(b) cardiopulmonary instability;
(c) severe coagulopathy (international normalized ratio > 1.5 or platelet count < 50,000 cells/cubic millimeter [cmm3]);
(d) inability to suspend antithrombotic therapy;
(e) pregnancy;
(f) refusal to provide informed consent or participate in the study.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the procurement rates of histologic cores that the cyto-pathologist considered to be of optimal quality for histological evaluation of the needle gauge used for the EUS-FNB procedure
- Secondary Outcome Measures
Name Time Method diagnostic performance: diagnostic accuracy, sensitivity, specificity, PPV, NPV;Technical failure;Procedure related adverse events